Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.36%1.78B | 2.59%1.79B | 0.80%1.9B | 6.83%7.26B | 5.18%1.91B | 8.16%1.72B | 5.65%1.74B | 8.46%1.89B | 2.52%6.79B | 2.83%1.82B |
| Operating revenue | 3.36%1.78B | 2.59%1.79B | 0.80%1.9B | 6.83%7.26B | 5.18%1.91B | 8.16%1.72B | 5.65%1.74B | 8.46%1.89B | 2.52%6.79B | 2.83%1.82B |
| Cost of revenue | -0.92%430M | 3.79%438M | 0.90%448M | 14.81%1.79B | 12.87%491M | 22.25%434M | 17.55%422M | 8.03%444M | -1.58%1.56B | -0.91%435M |
| Gross profit | 4.81%1.35B | 2.20%1.35B | 0.76%1.45B | 4.45%5.47B | 2.75%1.42B | 4.12%1.29B | 2.33%1.32B | 8.59%1.44B | 3.81%5.23B | 4.07%1.38B |
| Operating expense | -13.83%754M | -0.55%904M | -0.45%882M | 8.74%3.57B | -25.10%901M | 8.83%875M | 12.36%909M | 5.73%886M | 1.77%3.28B | 73.59%1.2B |
| Selling and administrative expenses | 0.00%674M | 0.75%670M | 2.38%644M | 4.93%2.66B | 4.23%690M | 12.33%674M | 7.26%665M | -3.38%629M | -5.24%2.53B | -3.07%662M |
| -General and administrative expense | 0.00%674M | 0.75%670M | 2.38%644M | 4.93%2.66B | 4.23%690M | 12.33%674M | 7.26%665M | -3.38%629M | -5.24%2.53B | -3.07%662M |
| Depreciation amortization depletion | 15.84%234M | 11.65%230M | 9.71%226M | 13.38%822M | 10.05%208M | 9.78%202M | 15.08%206M | 19.08%206M | 0.14%725M | 2.72%189M |
| -Depreciation and amortization | 15.84%234M | 11.65%230M | 9.71%226M | 13.38%822M | 10.05%208M | 9.78%202M | 15.08%206M | 19.08%206M | 0.14%725M | 2.72%189M |
| Other operating expenses | -15,300.00%-154M | -89.47%4M | -76.47%12M | 250.00%91M | -99.15%3M | -105.00%-1M | 280.00%38M | 264.29%51M | 115.29%26M | 302.30%352M |
| Operating profit | 44.10%598M | 8.31%443M | 2.70%570M | -2.77%1.9B | 192.09%517M | -4.60%415M | -14.61%409M | 13.50%555M | 7.44%1.95B | -72.04%177M |
| Net non-operating interest income (expenses) | -73.91%-40M | 15.38%-33M | 22.73%-34M | 8.16%-135M | 0.00%-29M | 25.81%-23M | -14.71%-39M | 16.98%-44M | 24.23%-147M | 43.14%-29M |
| Non-operating interest income | -53.85%12M | -35.29%11M | 45.45%16M | -10.59%76M | -12.00%22M | -13.33%26M | -37.04%17M | 10.00%11M | 962.50%85M | 733.33%25M |
| Non-operating interest expense | 6.38%50M | -13.21%46M | -9.80%46M | -15.19%201M | -10.71%50M | -24.19%47M | -13.11%53M | -21.54%51M | 16.18%237M | 3.70%56M |
| Total other finance cost | 0.00%2M | -166.67%-2M | 0.00%4M | 300.00%10M | 150.00%1M | 300.00%2M | -97.06%3M | 300.00%4M | -150.00%-5M | ---2M |
| Other net income (expenses) | 113.33%4M | -618.18%-57M | -146.43%-13M | 44.86%268M | -1.15%259M | -124.59%-30M | -95.49%11M | 138.36%28M | -59.87%185M | 162.38%262M |
| Gain on sale of security | 113.33%4M | -618.18%-57M | -146.43%-13M | 136.18%72M | 151.64%63M | -124.59%-30M | 110.68%11M | 129.17%28M | -143.17%-199M | 70.95%-122M |
| Special income (charges) | ---- | ---- | ---- | -48.96%196M | ---- | ---- | ---- | ---- | --384M | ---- |
| -Gain on sale of business | ---- | ---- | ---- | -48.96%196M | ---- | ---- | ---- | ---- | --384M | ---- |
| Income before tax | 55.25%562M | -7.35%353M | -2.97%523M | 2.06%2.03B | 82.20%747M | -31.18%362M | -44.70%381M | 48.48%539M | -4.51%1.99B | 153.09%410M |
| Income tax | 57.14%121M | 112.94%52M | 37.31%92M | -129.50%-123M | 575.00%135M | 527.78%77M | -283.56%-402M | -65.82%67M | 61.00%417M | -80.58%20M |
| Earnings from equity interest net of tax | -62.50%-13M | -106.56%-4M | 25.00%-6M | -96.28%40M | -101.92%-5M | 95.40%-8M | -85.44%61M | -101.40%-8M | 348.84%1.08B | 116.67%260M |
| Net income | 40.53%423M | -62.78%313M | -9.21%434M | -18.11%2.21B | -13.42%587M | -17.98%301M | -5.93%841M | -36.77%478M | 101.42%2.7B | 211.01%678M |
| Net income continuous operations | 54.51%428M | -64.81%297M | -8.41%425M | -17.16%2.19B | -6.62%607M | -25.14%277M | -5.06%844M | -37.04%464M | 90.22%2.65B | 263.13%650M |
| Net income discontinuous operations | -120.83%-5M | 633.33%16M | -35.71%9M | -69.39%15M | -171.43%-20M | 900.00%24M | -160.00%-3M | -26.32%14M | 192.45%49M | -28.21%28M |
| Noncontrolling interests | 0 | 0 | 0 | -3M | 0 | 0 | 0 | -3M | 0 | 0 |
| Net income attributable to the company | 40.53%423M | -62.78%313M | -9.77%434M | -18.00%2.21B | -13.42%587M | -17.98%301M | -5.93%841M | -36.38%481M | 101.42%2.7B | 211.01%678M |
| Preferred stock dividends | -50.00%1M | 0.00%1M | 0.00%5M | 0.00%2M | 0.00%1M | 66.67%5M | ||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 40.53%423M | -62.81%312M | -9.79%433M | -18.03%2.21B | -13.52%582M | -17.98%301M | -5.94%839M | -36.42%480M | 101.50%2.69B | 213.02%673M |
| Diluted earnings per share | 40.30%0.94 | -62.90%0.69 | -9.43%0.96 | -15.83%4.89 | -12.75%1.3 | -16.25%0.67 | -2.11%1.86 | -33.75%1.06 | 110.51%5.81 | 143.44%1.49 |
| Basic earnings per share | 40.30%0.94 | -62.90%0.69 | -9.43%0.96 | -15.69%4.89 | -12.75%1.3 | -16.25%0.67 | -2.11%1.86 | -33.33%1.06 | 110.91%5.8 | 143.44%1.49 |
| Dividend per share | 10.19%0.595 | 10.19%0.595 | 10.19%0.595 | 8.18%2.16 | 10.20%0.54 | 10.20%0.54 | 6.23%0.54 | 6.23%0.54 | 8.13%1.9966 | 6.14%0.49 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.